April 2024

Ontario individuals who are immunocompromised can get a fourth dose

Ontario individuals who are immunocompromised can get a fourth dose (booster) three months (84 days) after completion of the three-dose primary series. Please visit https://covid-19.ontario.ca/getting-covid-19-vaccine for more information.

< Back to Main List Next Article >

Lupus Blog Articles: Lupus lorem ipsum dolor sit amet est requiem deste natur.

Exploring Cognitive Fatigue and Brain Function in Lupus: New MRI Study Reveals Insights into Cognitive Impairment Mechanisms

Catalyst Grant News & Events

Article

Read

Scientists say they have identified a root cause of lupus — one that could pave the way for new treatments

Advocacy & Support Community & Awareness

Article

Read

Belimumab (Benlysta) Now Approved in Saskatchewan, Nova Scotia, and New Brunswick for Lupus Nephritis

Advocacy & Support Community & Awareness

Article

Read

Find What You’re Looking For

Find What You’re Looking For

Research

Clinical Trials

Find What You’re Looking For

Self Help

Support

Helpful Links

Find What You’re Looking For

Find What You’re Looking For

Find What You’re Looking For

Ontario individuals who are immunocompromised can get a fourth dose

Lupus Blog Articles: Lupus lorem ipsum dolor sit amet est requiem deste natur.

Exploring Cognitive Fatigue and Brain Function in Lupus: New MRI Study Reveals Insights into Cognitive Impairment Mechanisms

Scientists say they have identified a root cause of lupus — one that could pave the way for new treatments

Belimumab (Benlysta) Now Approved in Saskatchewan, Nova Scotia, and New Brunswick for Lupus Nephritis

About Lupus Canada

Understanding Lupus

Research & Clinical Trials

Finding Support & Help

Getting Involved

Our Lupus Resource

Contact Information